Fig. 2From: Incorporating Yttrium-90 trans-arterial radioembolization (TARE) in the treatment of metastatic pancreatic adenocarcioma: a single center experiencePre, intra, and post TARE imaging (a) Pre-procedural CT demonstrating a segment 4 metastatic pancreatic adenocarcinoma measuring 4.4 x 2.2 cm (b) Hepatic angiogram demonstrating enhancing segment 4 mass with aberrant arterial vasculature (c) 3 month post procedure CT demonstrating PR to TARE with lesion now measuring 2.8 x 1.8 cmBack to article page